Exane Derivatives’s Ally Financial ALLY Stock Holding History

Exane Derivatives’s Portfolio ALLY Stock Details ALLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.54K	Sell	46 -5,398	-99%	-$216K	﹤0.01%	464
2022 Q1	$237K	Sell	5,444 -620	-10%	-$29.3K	0.07%	293
2021 Q4	$289K	Buy	+6,064	New	+$300K	0.07%	267
2021 Q1	–	Sell	-1,111	Closed	-$39.6K	–	900
2020 Q4	$39.6K	Sell	1,111 -655	-37%	-$19.8K	0.01%	474
2020 Q3	$44.3K	Hold	1,766	–	–	0.01%	382
2020 Q2	$35K	Hold	1,766	–	–	0.01%	376
2020 Q1	$25.5K	Buy	1,766 +766	+77%	+$20.1K	0.01%	398
2019 Q4	$30.3K	Buy	+1,000	New	+$31.2K	0.01%	380

Other funds holding ALLY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Exane Derivatives's ALLY Position: Q2 2022 in Review

Exane Derivatives reduced its Ally Financial (ALLY) stake by 99% in Q2 2022, selling an estimated $216K and leaving 46 shares worth $1.54K. The position accounts for ﹤0.01% of the portfolio, ranked #464.

Exane Derivatives first reported a position in ALLY in Q4 2019 and has held it in 8 quarters since. The position peaked at $289K in Q4 2021. 566 funds tracked by Wall St. Rank hold ALLY as of Q2 2022.

Exane Derivatives held 46 shares of Ally Financial worth $1.54K as of Q2 2022.
Exane Derivatives sold 5,398 Ally Financial shares in Q2 2022, an estimated $216K.
Ally Financial made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #464 holding.
Exane Derivatives first reported a position in Ally Financial in Q4 2019 and has held it in 8 quarters since.
Exane Derivatives's Ally Financial position peaked at $289K in Q4 2021.
566 funds tracked by Wall St. Rank held Ally Financial as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.